EP
MBOT icon

Evelyn Partners’s Microbot Medical MBOT Stock Holding History

Evelyn Partners’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Buy
+1
New +$2 ﹤0.01% 550

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Evelyn Partners's MBOT Position: Q2 2026 in Review

Evelyn Partners opened a new position in Microbot Medical (MBOT) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #550 among its holdings.

69 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Evelyn Partners held 1 share of Microbot Medical worth $2 as of Q2 2026.
  • Microbot Medical was a new Evelyn Partners position in Q2 2026.
  • Microbot Medical made up ﹤0.01% of Evelyn Partners's portfolio in Q2 2026, its #550 holding.
  • 69 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.